A detailed history of Nisa Investment Advisors, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 740 shares of SAGE stock, worth $4,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
740
Previous 6,230 88.12%
Holding current value
$4,240
Previous $67,000 92.54%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$7.02 - $13.08 $38,539 - $71,809
-5,490 Reduced 88.12%
740 $5,000
Q2 2024

Jul 19, 2024

SELL
$10.58 - $17.9 $136,323 - $230,641
-12,885 Reduced 67.41%
6,230 $67,000
Q1 2024

May 01, 2024

BUY
$18.62 - $26.95 $1,396 - $2,021
75 Added 0.39%
19,115 $358,000
Q4 2023

Jan 25, 2024

BUY
$17.1 - $22.26 $316,179 - $411,587
18,490 Added 3361.82%
19,040 $412,000
Q3 2023

Nov 02, 2023

SELL
$16.75 - $48.98 $24,773 - $72,441
-1,479 Reduced 72.89%
550 $11,000
Q2 2023

Aug 11, 2023

BUY
$40.65 - $59.54 $21,951 - $32,151
540 Added 36.27%
2,029 $95,000
Q4 2022

Feb 02, 2023

SELL
$32.2 - $43.61 $4,508 - $6,105
-140 Reduced 8.59%
1,489 $57,000
Q3 2022

Nov 07, 2022

BUY
$32.28 - $43.27 $2,905 - $3,894
90 Added 5.85%
1,629 $61,000
Q2 2022

Aug 03, 2022

BUY
$27.52 - $37.99 $39,904 - $55,085
1,450 Added 1629.21%
1,539 $50,000
Q1 2022

Apr 29, 2022

SELL
$30.71 - $45.71 $3,838 - $5,713
-125 Reduced 58.41%
89 $3,000
Q4 2021

Feb 03, 2022

SELL
$37.06 - $47.11 $4,484 - $5,700
-121 Reduced 36.12%
214 $8,000
Q3 2021

Oct 18, 2021

SELL
$40.26 - $57.37 $68,522 - $97,643
-1,702 Reduced 83.55%
335 $15,000
Q2 2021

Aug 06, 2021

SELL
$54.88 - $79.29 $49,392 - $71,361
-900 Reduced 30.64%
2,037 $116,000
Q4 2020

Jan 25, 2021

BUY
$58.41 - $89.06 $111,679 - $170,282
1,912 Added 186.54%
2,937 $254,000
Q2 2020

Jul 27, 2020

SELL
$25.95 - $43.15 $96,793 - $160,949
-3,730 Reduced 78.44%
1,025 $43,000
Q1 2020

Apr 17, 2020

BUY
$26.15 - $77.24 $19,612 - $57,929
750 Added 18.73%
4,755 $137,000
Q4 2019

Jan 17, 2020

SELL
$60.18 - $154.77 $767,896 - $1.97 Million
-12,760 Reduced 76.11%
4,005 $289,000
Q3 2019

Oct 17, 2019

BUY
$140.29 - $189.96 $2.33 Million - $3.15 Million
16,590 Added 9480.0%
16,765 $2.35 Million
Q1 2019

Apr 17, 2019

SELL
$89.33 - $163.65 $172,406 - $315,844
-1,930 Reduced 91.69%
175 $28,000
Q3 2018

Oct 16, 2018

BUY
$138.11 - $169.04 $266,552 - $326,247
1,930 Added 1102.86%
2,105 $297,000
Q2 2018

Jul 19, 2018

SELL
$140.36 - $175.76 $31,581 - $39,546
-225 Reduced 56.25%
175 $27,000
Q1 2018

Apr 10, 2018

SELL
$152.15 - $192.33 $7,607 - $9,616
-50 Reduced 11.11%
400 $64,000
Q4 2017

Jan 12, 2018

BUY
$60.72 - $167.34 $2,428 - $6,693
40 Added 9.76%
450 $74,000
Q3 2017

Oct 13, 2017

BUY
$61.4 - $88.52 $25,174 - $36,293
410
410 $26,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.